Advertisement

Bold Action to Meet Women's Needs: Putting Abortion Pills in U.S. Women's Hands

Published:September 22, 2015DOI:https://doi.org/10.1016/j.whi.2015.08.004
      Imagine two women, each facing an unintended pregnancy and living where legal restrictions make it impossible for her to get an abortion under the care of a trained medical provider. A woman going through this experience in many countries in Latin America, Asia, and Africa is likely to know, or learn from a friend, that she can take medications on her own to have an abortion safely.
      Misoprostol and mifepristone are registered in 90 and 50 countries, respectively (
      • Winikoff B.
      • Sheldon W.
      Use of medicines changing the face of abortion.
      ).
      1Misoprostol and mifepristone are registered in 90 and 50 countries, respectively (
      • Winikoff B.
      • Sheldon W.
      Use of medicines changing the face of abortion.
      ).
      She can get the pills at a pharmacy and take them in her own home.
      To read this article in full you will need to make a payment
      Subscribe to Women's Health Issues
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • American College of Obstetricians and Gynecologists
        Practice bulletin 143: Medical management of first-trimester abortion.
        Obstetrics and Gynecology. 2014; 123: 676-692
      1. Bazelon, E. (2014, September 22). A mother in jail for helping her daughter have an abortion. New York Times. Available: http://www.nytimes.com/2014/09/22/magazine/a-mother-in-jail-for-helping-her-daughter-have-an-abortion.html?_r=0. Accessed September 9, 2015.

        • Boonstra H.
        Medication abortion restrictions burden women and providers and threaten U.S. trend toward very early abortion.
        Guttmacher Policy Review. 2013; 16: 18-23
        • Coeytaux F.
        • Moore K.
        • Gelberg L.
        Convincing new providers to offer medical abortion: What will it take?.
        Perspectives on Sexual and Reproductive Health. 2003; 59: 44-47
        • Coeytaux F.
        • Pillsbury B.
        Bringing emergency contraception to American women: The history and remaining challenges.
        Women's Health Issues. 2001; 11: 80-86
      2. Consensus statement: Instructions for use-abortion induction with misoprostol in pregnancies up to 9 weeks LMP. Expert Meeting on Misoprostol sponsored by Reproductive Health Technologies Project and Gynuity Health Projects. 2003 Jul 28. Washington, DC.

        • Debrez E.
        Texas threat to abortion clinics dodged at flea markets.
        Bloomberg. 2013, July 11; (Available:) (Accessed September 9, 2015)
      3. Eckholm, E. (2013, July 13). A pill available in Mexico is a Texas option for abortion. New York Times. Available: http://www.nytimes.com/2013/07/14/us/in-mexican-pill-a-texas-option-for-an-abortion.html. Accessed September 9, 2015.

        • Foster A.M.
        • Wynn L.L.
        Emergency contraception: The story of a global reproductive health technology.
        Palgrave Macmillan, Basingstoke, Hampshire, England2012
        • Ganatra B.
        • Tuncalp O.
        • Johnston H.B.
        • Johnson B.R.
        • Gulmezoglu A.M.
        • Temmerman M.
        From concept to measurement: Operationalizing WHO's definition of unsafe abortion.
        Bulletin of the World Health Organization. 2014; 92: 153-228
      4. Greenhouse, L. (2013, September 4). The next abortion case is here. New York Times. Available: http://opinionator.blogs.nytimes.com/2013/09/04/the-next-abortion-case-is-here/. Accessed September 9, 2015.

        • Grossman D.
        • Holt K.
        • Peña M.
        • Lara D.
        • Veatch M.
        • Córdova D.
        Self-induction of abortion among women in the United States.
        Reproductive Health Matters. 2010; 18: 136-146
        • Grossman D.
        • Garcia S.
        • Kingston J.
        • Schweikert S.
        Mexican women seeking safe abortion services in San Diego, California.
        Health Care for Women International. 2012; 33: 1060-1069
      5. Guttmacher Institute. (2014). Facts on induced abortion. Available: www.guttmacher.org/pubs/fb_induced_abortion.html. Accessed September 9, 2015.

      6. Hellerstein, E. (2014, June 27). The rise of the DIY abortion in Texas. The Atlantic. Available: http://www.theatlantic.com/health/archive/2014/06/the-rise-of-the-diy-abortion-in-texas/373240/. Accessed September 9, 2015.

      7. Hoffman, J. (1993, January 10). The morning-after pill: A well-kept secret. New York Times. Available: http://www.nytimes.com/1993/01/10/magazine/the-morning-after-pill-a-well-kept-secret.html. Accessed September 9, 2015.

      8. International Women's Health Coalition, Gynuity Health Projects. (2010). Abortion with self-administered misoprostol: A guide for women. Available: http://iwhc.org/resource/abortion-self-administered-misoprostol-guide-women/. Accessed September 9, 2015.

      9. Jarvie, J. (2015, June 10). Murder charge dropped against Georgia woman who took pills for abortion. LA Times. Available: http://www.latimes.com/nation/la-na-abortion-murder-20150611-story.html. Accessed September 9, 2015.

        • Jones R.
        How commonly do US abortion patients report attempts to self-induce?.
        American Journal of Obstetrics and Gynecology. 2010; 204: 23.e1-23.e4
        • Jones R.K.
        • Kooistra K.
        Abortion incidence and access to services in the United States.
        Perspectives on Sexual and Reproductive Health. 2011; 43: 41-50
        • Kulier R.
        • Kapp N.
        • Gulmezoglu A.M.
        • Hofmeyr G.J.
        • Cheng L.
        • Campana A.
        Medical methods for first trimester abortion.
        Cochrane Database of Systematic Reviews. 2011; 11 (CD002855)
        • Lafaurie M.M.
        • Grossman D.
        • Toncoso E.
        • Billings D.L.
        • Chavez S.
        Women's perspectives on medical abortion in Mexico, Colombia, Ecuador and Peru: A qualitative study.
        Reproductive Health Matters. 2005; 13: 75-83
        • Lara D.
        • Abuabara K.
        • Grossman D.
        • Díaz-Olavarrieta C.
        Pharmacy provision of medical abortifacients in a Latin American city.
        Contraception. 2006; 74: 394-399
      10. MedLine Plus. (2013). Misoprostol [website]. Available: www.nlm.nih.gov/medlineplus/druginfo/meds/a689009.html. Accessed September 9, 2015.

      11. Mifeprex Prescriber's Agreement. (2005). Available: http://earlyoptionpill.com/wp-content/uploads/2014/04/Mifeprex_Labeling_Prescribers_Agreement.pdf. Accessed September 9, 2015.

        • Moreno-Ruiz N.L.
        • Borgatta L.
        • Yanow S.
        • Kapp N.
        • Wiebe E.R.
        • Winikoff B.
        Alternatives to mifepristone for early medical abortion.
        International Journal of Obstetrics and Gynecology. 2007; 96: 212-218
        • Ngo T.D.
        • Park M.H.
        • Shakur H.
        • Free C.
        Comparative effectiveness, safety and acceptability of medical abortion at home and in a clinic: A systematic review.
        Bulletin of the World Health Organization. 2011; 89: 360-370
        • Ngoc N.T.N.
        • Blum J.
        • Raghavan S.
        • Nga N.T.
        • Dabash R.
        • Diop A.
        • Winikoff B.
        Comparing two early medical abortion regimens: Mifepristone+misoprostol vs. misoprostol alone.
        Contraception. 2011; 83: 410-417
        • Paltrow L.,
        • Flavin J.
        Arrests of and forced interventions on pregnant women in the United States, 1973–2005: Implications for women's legal status and public health.
        Journal of Health Politics, Policy and Law. 2013; 38: 299-343
      12. Pieklo, J. M. (2015a, February 4). Purvi Patel convicted of feticide and neglect of dependent. RH Reality Check. Available: http://rhrealitycheck.org/article/2015/02/04/purvi-patel-convicted-feticide-neglect-dependent/. Accessed September 10, 2015.

      13. Pieklo, J. (2015b, May 29). Ninth Circuit Court strikes another 20-week abortion ban. RH Reality Check. Available: http://rhrealitycheck.org/article/2015/05/29/ninth-circuit-court-strikes-another-20-week-abortion-ban/. Accessed September 10, 2015.

        • Pillsbury B.
        • Coeytaux F.
        • Johnston A.
        From secret to shelf: How collaboration is bringing emergency contraception to women.
        Pacific Institute for Women's Health, Los Angeles1999
        • Robinson J.
        Idaho woman arrested for abortion is uneasy case for both sides.
        NPR. 2012, April 9; (Available:) (Accessed September 9, 2015)
        • Rosing M.
        • Archibald C.
        The knowledge, acceptability, and use of misoprostol for self-induced medical abortion in an urban US population.
        Journal of the American Medical Women's Association. 2000; 55: 183-185
        • Shah I.
        • Weinburger M.B.
        Expanding access to medical abortion: Perspectives of women and providers in developing countries.
        International Journal of Obstetrics and Gynecology. 2012; 118: S1-S3
        • Sherris J.
        • Bingham A.
        • Burns M.A.
        • Girvin S.
        • Westley E.
        • Gomez P.I.
        Misoprostol use in developing countries: Results from a multicountry study.
        International Journal of Obstetrics and Gynecology. 2005; 88: 76-78
        • von Hertzen H.
        • Piaggio G.
        • Huong N.T.M.
        • Arustamyan K.
        • Cabezas E.
        • Gomez M.
        • et al.
        • WHO Research Group on Postovulatory Methods of Fertility Regulation.
        Efficacy of two intervals and two routes of administration of misoprostol for termination of pregnancy: A randomised controlled equivalence trial.
        The Lancet. 2007; 369: 1938-1946
        • Winikoff B.
        • Sheldon W.
        Use of medicines changing the face of abortion.
        International Perspectives on Sexual and Reproductive Health. 2012; 38: 164-168
        • World Health Organization (WHO)
        Safe abortion: Technical and policy guidance for health systems.
        2nd ed. Author, Geneva2012
      14. Yanow, S. (2009). The Best Defense is a Good Offense: Misoprostol, Abortion, and the law. Conference Summary and Strategic Recommendations. Cosponsored by Gynuity Health Projects and the Reproductive Health Technologies Project. New York City, New York, August 27–28, 2009.

        • Yanow S.
        Positive legal precedent set in case against a woman who self-induced abortion: A rare victory for women in the United States.
        Reproductive Health Matters. 2012; 20: 175-176

      Biography

      Francine Coeytaux, MPH, Public Health Institute, has more than 40 years of experience working in Africa, Latin America, and the United States, advocating for reproductive rights and promoting the development of new reproductive technologies, including emergency contraception, medication abortion, and microbicides.

      Biography

      Leila Hessini, MPH, MA, is Director of Community Mobilization and Women's Organizing at Ipas. Her global experience is informed by extensive residency in Egypt, Morocco, France, and the United States and engagement with women's human rights advocates in more than 40 countries.

      Biography

      Amy Allina, BA, is a senior leader in reproductive health, rights and justice. She served previously as Deputy Director of the National Women's Health Network and is a co-founder of Raising Women's Voices for the Health Care We Need.